Cargando…
Novel sulphamoylated 2-methoxy estradiol derivatives inhibit breast cancer migration by disrupting microtubule turnover and organization
BACKGROUND: The estrogen metabolite 2-methoxyestradiol (2ME2) and a number of synthesised derivatives have been shown to bind to microtubules thereby arresting cancer cells in mitosis which leads to apoptosis. In interphase cells, microtubules play an important role in the delivery of proteins to su...
Autores principales: | van Vuuren, Rustelle Janse, Botes, Mandie, Jurgens, Tamarin, Joubert, Anna Margaretha, van den Bout, Iman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317210/ https://www.ncbi.nlm.nih.gov/pubmed/30622437 http://dx.doi.org/10.1186/s12935-018-0719-4 |
Ejemplares similares
-
Correction to: Novel sulphamoylated 2-methoxy estradiol derivatives inhibit breast cancer migration by disrupting microtubule turnover and organization
por: van Vuuren, Rustelle Janse, et al.
Publicado: (2020) -
A novel non-sulphamoylated 2-methoxyestradiol derivative causes detachment of breast cancer cells by rapid disassembly of focal adhesions
por: Botes, Mandie, et al.
Publicado: (2018) -
A bis-sulphamoylated estradiol derivative induces ROS-dependent cell cycle abnormalities and subsequent apoptosis
por: Visagie, Michelle Helen, et al.
Publicado: (2017) -
Sulphamoylated estradiol analogue induces antiproliferative activity and apoptosis in breast cell lines
por: Visagie, Michelle, et al.
Publicado: (2012) -
Autophagy induced by a sulphamoylated estrone analogue contributes to its cytotoxic effect on breast cancer cells
por: Verwey, Marcel, et al.
Publicado: (2016)